temozolomide has been researched along with erteberel in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brenner, A; Cavazos, D; Garcia, L; Garcia, M; Gruslova, A; Gustafsson, JA; Li, X; Liu, J; Sareddy, GR; Strom, AM; Tekmal, RR; Vadlamudi, RK; Viswanadhapalli, S | 1 |
1 other study(ies) available for temozolomide and erteberel
| Article | Year |
|---|---|
Selective Estrogen Receptor β Agonist LY500307 as a Novel Therapeutic Agent for Glioblastoma.
Topics: Animals; Antineoplastic Agents; Apoptosis; Benzopyrans; Brain Neoplasms; Caspase 3; Cell Line, Tumor; Cisplatin; Dacarbazine; DNA Repair; Estrogen Receptor beta; G2 Phase Cell Cycle Checkpoints; Gene Expression Regulation; Glioblastoma; Humans; Mice; Mice, Inbred C57BL; Mice, Nude; Proto-Oncogene Proteins c-bcl-2; Temozolomide; Xenograft Model Antitumor Assays | 2016 |